Sarah Morris

401 total citations
18 papers, 229 citations indexed

About

Sarah Morris is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Sarah Morris has authored 18 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Sarah Morris's work include Pharmacogenetics and Drug Metabolism (6 papers), Colorectal Cancer Treatments and Studies (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Sarah Morris is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Colorectal Cancer Treatments and Studies (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Sarah Morris collaborates with scholars based in United States, United Kingdom and Australia. Sarah Morris's co-authors include Jai N. Patel, Joseph E. Bauer, Mark V. Williams, Jean Edward, Cyrine E. Haidar, Mary V. Relling, Michelle Whirl‐Carrillo, Roseann S. Gammal, Amanda Fallin and Christine M. Formea and has published in prestigious journals such as Journal of Clinical Oncology, PEDIATRICS and Molecular Psychiatry.

In The Last Decade

Sarah Morris

17 papers receiving 226 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Morris United States 7 82 67 36 31 31 18 229
Catherine Chanfreau‐Coffinier United States 8 94 1.1× 65 1.0× 56 1.6× 14 0.5× 44 1.4× 31 256
Narith N. Ou United States 11 186 2.3× 105 1.6× 33 0.9× 14 0.5× 71 2.3× 23 465
Jonathan Thigpen United States 8 79 1.0× 20 0.3× 15 0.4× 17 0.5× 16 0.5× 19 295
Mary Jayne Kennedy United States 12 67 0.8× 89 1.3× 47 1.3× 23 0.7× 9 0.3× 24 316
Randall W. Knoebel United States 12 30 0.4× 108 1.6× 28 0.8× 59 1.9× 11 0.4× 35 315
Sireen Abdul Rahim Shilbayeh Saudi Arabia 10 24 0.3× 49 0.7× 23 0.6× 48 1.5× 10 0.3× 51 276
P Bertault-Pérès France 10 81 1.0× 85 1.3× 16 0.4× 75 2.4× 7 0.2× 20 328
Samantha Alvarez‐Madrazo United Kingdom 12 30 0.4× 25 0.4× 26 0.7× 13 0.4× 22 0.7× 19 508
Youssef M. Roman United States 13 70 0.9× 19 0.3× 15 0.4× 48 1.5× 57 1.8× 41 434
Erwin Cabacungan United States 12 117 1.4× 148 2.2× 18 0.5× 67 2.2× 19 0.6× 30 440

Countries citing papers authored by Sarah Morris

Since Specialization
Citations

This map shows the geographic impact of Sarah Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Morris more than expected).

Fields of papers citing papers by Sarah Morris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Morris. The network helps show where Sarah Morris may publish in the future.

Co-authorship network of co-authors of Sarah Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Morris. A scholar is included among the top collaborators of Sarah Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Morris. Sarah Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Morris, Sarah, et al.. (2024). Integrating pharmacogenomic results in the electronic health record to facilitate precision medicine at a large multisite health system. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 7(8). 845–857. 4 indexed citations
2.
Morris, Sarah, Alicia Hamilton, Nury Steuerwald, et al.. (2024). Real-World Impact of an In-House Dihydropyrimidine Dehydrogenase (DPYD) Genotype Test on Fluoropyrimidine Dosing, Toxicities, and Hospitalizations at a Multisite Cancer Center. JCO Precision Oncology. 8(8). e2300623–e2300623. 9 indexed citations
3.
Steuerwald, Nury, et al.. (2024). Understanding the Biology and Testing Techniques for Pharmacogenomics in Oncology: A Practical Guide for the Clinician. JCO Oncology Practice. 20(11). 1441–1451. 3 indexed citations
4.
Patel, Jai N., Sarah Morris, Raúl Torres, et al.. (2024). Pharmacogenomic insights in psychiatric care: uncovering novel actionability, allele-specific CYP2D6 copy number variation, and phenoconversion in 15,000 patients. Molecular Psychiatry. 29(11). 3495–3502. 2 indexed citations
5.
Morris, Sarah, Donald C. Moore, Sarah L. Hanson, et al.. (2024). Unveiling Discrepant and Rare Dihydropyrimidine Dehydrogenase (DPYD) Results Using an In-House Genotyping Test: A Case Series. Journal of the National Comprehensive Cancer Network. 22(4). 3 indexed citations
6.
Patel, Jai N., Sarah Morris, Alicia Hamilton, et al.. (2023). Real-world experience of an in-house dihydropyrimidine dehydrogenase (DPYD) genotype test to guide fluoropyrimidine (FP) dosing at a multisite cancer hospital.. Journal of Clinical Oncology. 41(16_suppl). 1534–1534. 1 indexed citations
7.
Morris, Sarah, et al.. (2023). COVID-19 vaccine acceptance in three rural communes in Haiti: A cross-sectional study. Human Vaccines & Immunotherapeutics. 19(1). 2204048–2204048. 4 indexed citations
8.
Morris, Sarah, et al.. (2023). Pharmacogenomics in allogeneic hematopoietic stem cell transplantation: Implications on supportive therapies and conditioning regimens. Best Practice & Research Clinical Haematology. 36(2). 101470–101470.
9.
Patel, Jai N., Myra Robinson, Sarah Morris, et al.. (2023). Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing. The Pharmacogenomics Journal. 23(6). 201–209. 2 indexed citations
10.
Morris, Sarah, Donald C. Moore, Laura W. Musselwhite, et al.. (2023). Addressing barriers to increased adoption of DPYD genotyping at a large multisite cancer center. American Journal of Health-System Pharmacy. 80(19). 1342–1349. 7 indexed citations
11.
Gammal, Roseann S., Munir Pirmohamed, Andrew A. Somogyi, et al.. (2022). Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype. Clinical Pharmacology & Therapeutics. 113(5). 973–985. 28 indexed citations
12.
Morris, Sarah, et al.. (2022). Cost Effectiveness of Pharmacogenetic Testing for Drugs with Clinical Pharmacogenetics Implementation Consortium ( CPIC ) Guidelines: A Systematic Review. Clinical Pharmacology & Therapeutics. 112(6). 1318–1328. 83 indexed citations
13.
Morris, Sarah, Kristine R. Crews, Randall T. Hayden, et al.. (2021). Incorporating G6PD genotyping to identify patients with G6PD deficiency. Pharmacogenetics and Genomics. 32(3). 87–93. 6 indexed citations
14.
Kerr, Zachary Y., Karen G. Roos, Andrew E. Lincoln, et al.. (2019). Injury Incidence in Youth, High School, and NCAA Men’s Lacrosse. PEDIATRICS. 143(6). 16 indexed citations
15.
Edward, Jean, et al.. (2018). The impact of health and health insurance literacy on access to care for Hispanic/Latino communities. Public Health Nursing. 35(3). 176–183. 40 indexed citations
16.
Bolam, Thi, et al.. (2016). Cadmium levels in food containing crab brown meat: A brief survey from UK retailers. Journal of Food Composition and Analysis. 54. 63–69. 6 indexed citations
17.
Fallin, Amanda, Amie Goodin, Mary Kay Rayens, Sarah Morris, & Ellen J. Hahn. (2014). Smoke-Free Policy Implementation: Theoretical and Practical Considerations. Policy Politics & Nursing Practice. 15(3-4). 81–92. 11 indexed citations
18.
Morris, Sarah, et al.. (2013). Building a youth-led movement to keep young people out of the adult criminal justice system. Children and Youth Services Review. 35(8). 1268–1275. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Chanfreau‐Coffinier Breakdown of academic impact, for papers by Narith N. Ou Breakdown of academic impact, for papers by Jonathan Thigpen Breakdown of academic impact, for papers by Mary Jayne Kennedy Breakdown of academic impact, for papers by Randall W. Knoebel Breakdown of academic impact, for papers by Sireen Abdul Rahim Shilbayeh Breakdown of academic impact, for papers by P Bertault-Pérès Breakdown of academic impact, for papers by Samantha Alvarez‐Madrazo Breakdown of academic impact, for papers by Youssef M. Roman Breakdown of academic impact, for papers by Erwin Cabacungan
Rankless by CCL
2026